Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Name: Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
SKU: prod_a69c0a7a171779699a028319

1 store 1 in stock

Compare prices from 2,215 kr

Go to Bokus

Prices checked 2 months ago

Double-check the price at PriceRunner Prisjakt

1 offer

In stock only

Bokus Lowest price

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

In stock Checked 2 months ago

2,215 kr

Go to store

We started tracking the price 31 Jul 2026. Price history appears once the price changes.